Delivery Order SPE2DB20D1100-SPE2DB25FC9S3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,131.33 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This non-competitive delivery order, issued on September 19, 2025, represents a firm fixed price purchase with an ultimate completion date of September 22, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,287.63 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed-price contract, awarded on August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency has awarded a delivery order valued at $1,694.39 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed price, competitively awarded contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which was competitively awarded with no set-aside designation, is effective through August 11, 2025, and utilizes firm fixed pricing. AmerisourceBergen will perform fulfillment from its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,163.54 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a non-set-aside, competitive basis and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,901.57 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation, indicating it was...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9S3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,891.14 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which became effective on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. This delivery order falls within AmerisourceBergen's extensive portfolio of federal medical supply contracts with DLA, which demonstrates the company's capability to meet specialized healthcare procurement requirements through open competition. The Dexcom G7 sensors represent continuous glucose monitoring devices critical for diabetes management across the military and veteran healthcare systems. The compact nature of this individual delivery order exemplifies how the broader IDC framework enables flexible procurement of specific medical products to support Defense Health Agency operations and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 6/18/25 |